The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells
Published inBiochemical pharmacology, vol. 79, no. 12, p. 1827-1836
Publication date2010
Abstract
Keywords
- Animals
- Bromocriptine/*pharmacology
- Cell Line
- Dopamine Agonists/*pharmacology
- Dose-Response Relationship, Drug
- Glucose/pharmacology
- Insulin/*secretion
- Insulin-Secreting Cells/*drug effects/metabolism
- Insulinoma
- Male
- Mice
- Mice, Inbred C57BL
- Rats
- Receptors, Adrenergic, alpha/*metabolism
- Receptors, Dopamine D2/*agonists
Research group
Citation (ISO format)
DE LEEUW VAN WEENEN, J. E. et al. The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells. In: Biochemical pharmacology, 2010, vol. 79, n° 12, p. 1827–1836. doi: 10.1016/j.bcp.2010.01.029
Main files (1)
Article
Identifiers
- PID : unige:20882
- DOI : 10.1016/j.bcp.2010.01.029
- PMID : 20138024
ISSN of the journal0006-2952